pubmed-article:16820264 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0015385 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0205095 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0002708 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0152335 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0228418 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0041491 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0058697 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0066908 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0205753 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
pubmed-article:16820264 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
pubmed-article:16820264 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16820264 | pubmed:dateCreated | 2006-8-21 | lld:pubmed |
pubmed-article:16820264 | pubmed:abstractText | Mismatches between dopamine innervation and dopamine D1 receptor (D1) distribution have previously been demonstrated in the intercalated cell masses of the rat amygdala. Here the distribution of enkephalin and beta-endorphin immunoreactive (IR) nerve terminals with respect to their mu-opioid receptors is examined in the intercalated cell masses, along with a further immunohistochemical analysis of the dopamine/D1 mismatches. A similar analysis is also made within the extended amygdala. A spatial mismatch in distribution patterns was found between the mu-opioid receptor-1 immunoreactivity and enkephalin IR in the main intercalated island of the amygdala. Discrete cell patches of dopamine D1 receptor and mu-opioid receptor-1 IR were also identified in a distinct region of the extended amygdala, the interstitial nucleus of the posterior limb of the anterior commissure, medial division (IPACM), which displayed sparse tyrosine hydroxylase or enkephalin/beta-endorphin IR nerve terminals. Furthermore, distinct regions of the main intercalated island that showed dopamine/D1 receptor matches (the rostral and rostrolateral parts) were associated with strong dopamine and cyclic AMP regulated phosphoprotein, 32 kDa-IR in several D1 IR neuronal cell bodies and dendrites, whereas this was not the case for the dopamine/D1 mismatch areas (the rostromedial and caudal parts) of the main intercalated island. The lack of correlation between the terminal/receptor distribution patterns suggests a role for volume transmission for mu-opioid receptor- and dopamine D1 receptor-mediated transmission in distinct regions of the amygdala and extended amygdala. This may have implications for amygdaloid function, where slow long lasting responses may develop as a result of volume transmission operating in opioid peptide and dopaminergic communication. | lld:pubmed |
pubmed-article:16820264 | pubmed:language | eng | lld:pubmed |
pubmed-article:16820264 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16820264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16820264 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16820264 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16820264 | pubmed:issn | 0306-4522 | lld:pubmed |
pubmed-article:16820264 | pubmed:author | pubmed-author:FuxeKK | lld:pubmed |
pubmed-article:16820264 | pubmed:author | pubmed-author:StainesW AWA | lld:pubmed |
pubmed-article:16820264 | pubmed:author | pubmed-author:HöistadMM | lld:pubmed |
pubmed-article:16820264 | pubmed:author | pubmed-author:JacobsenK XKX | lld:pubmed |
pubmed-article:16820264 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16820264 | pubmed:day | 15 | lld:pubmed |
pubmed-article:16820264 | pubmed:volume | 141 | lld:pubmed |
pubmed-article:16820264 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16820264 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16820264 | pubmed:pagination | 2007-18 | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:meshHeading | pubmed-meshheading:16820264... | lld:pubmed |
pubmed-article:16820264 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16820264 | pubmed:articleTitle | The distribution of dopamine D1 receptor and mu-opioid receptor 1 receptor immunoreactivities in the amygdala and interstitial nucleus of the posterior limb of the anterior commissure: relationships to tyrosine hydroxylase and opioid peptide terminal systems. | lld:pubmed |
pubmed-article:16820264 | pubmed:affiliation | Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smythe Road, Ottawa, Ontario K1H 8M5, Canada. kjaco031@uottawa.ca | lld:pubmed |
pubmed-article:16820264 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16820264 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16820264 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16820264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16820264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16820264 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16820264 | lld:pubmed |